The Global Gamma Knife Market was valued at US$ 174.4 million in 2016 and is projected to expand at a CAGR of 7.7% during the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Increase in patient awareness about the disease and gamma knife technology would increase the patient flow at the gamma knife centers thus stimulating more installations worldwide.
Currently, there are more than 300 gamma knife centers globally. Africa, Middle East and Latin America regions are identified with a few lesser gamma knife centers compared to North America, Europe and Asia. Seven centers in the U.S. had ordered the new gamma knife Icon system in 2015 representing the preference for this platform in treating cranial indications. Samsung Medical Center (SMS) in Seoul—one of the busiest gamma knife radiosurgery centers in Asia after China—was the first center in Asia to acquire Leksell Gamma Knife Icon system in 2015. The Icon system offers frameless treatment with similar accuracy as that of frame-based treatment. Moreover, this new addition to the Leksell Gamma Knife system has an integrated image guidance system and an Online Adaptive Dose Control option to ensure that the dose reaches the target location.
To know the latest trends and insights prevalent in the gamma knife market, click the link below:
Adoption of gamma knife technology is on rise and has gained traction in recent years. Though the technology was introduced decades ago, the exorbitantly high costs associated with them dissuaded its large scale adoption across the healthcare sector. Average cost of gamma knife system is over US $5 million. This was a major reason for the gamma knife market to be deprived of potential demand. On contrary, over 2,500 research studies are available for gamma knife technology which can be a major convincing factor for adoption of gamma knife technology.
Gamma knife can however be cost competitive only when demand for intracranial stereotactic radiosurgery (SRS) is high enough to allow maximum utilization of gamma knife system. Low patient flow makes the system capital intensive for the organization. To improve the gamma knife market condition it is essential to create awareness about the disease and availability of this precision therapy.
The U.S. federal government reduced Medicare reimbursement for gamma knife treatment from US $8,100 to US $3,400 in 2013. This further reduces the accessibility of a highly precise brain tumor treatment method to the general population in the U.S. Although an alternative technology, Cyber Knife, is available, many physician prefer using gamma knife over linac-based surgery based on their comfort and skills. Therefore, the gamma knife market is expected to experience a gradual growth.
Key takeaways of the market:
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Email: [email protected]
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.